# OX2 Therapeutics, Inc.: Form D filings

OX2 Therapeutics, Inc., a biotechnology company in Minneapolis, MN, filed 2 Form D notices with the SEC between 2017 and 2020. The latest, on September 22, 2020, reports $649,415 sold of a $750,007 offering to 15 investors.

Find out what OX2 Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20OX2%20Therapeutics%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=OX2%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fox2-therapeutics-inc-1704490)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20OX2%20Therapeutics%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=OX2%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fox2-therapeutics-inc-1704490)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Minnesota](https://specstream.ai/data/form-d/state/minnesota): 692 rows, by operating companies, filed since November 1, 2024, $34.60, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/minnesota
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1621 E. Hennepin Avenue, Suite 290, Minneapolis, MN, 55414
- Phone: (612) 309-7653
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2016
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1704490

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sep 22, 2020 | New notice | $750,007 | $649,415 | $100,592 | 15 | Aug 20, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1704490/000143774920019981/0001437749-20-019981-index.htm) |
| May 17, 2017 | New notice | $3,060,997 | $305,002 | $2,755,995 | 4 | Mar 29, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1704490/000120919117033212/0001209191-17-033212-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Rob Parish | Director |  |
| Ben Oehler | Director |  |
| Christopher Moertel | Executive Officer, Director |  |
| Jeff Liter | Executive Officer, Promoter |  |
| Andrea Hunt | Director |  |
| Mike Olin | Executive Officer, Director |  |

## Other biotechnology companies in Minnesota that filed recently

- [Medical 21, Inc.](https://specstream.ai/data/form-d/company/medical-21-inc-1673688) $550,000 · Oct 23, 2026
- [InSitu Biologics, Inc.](https://specstream.ai/data/form-d/company/insitu-biologics-inc-1723443) $1.3 million · Oct 14, 2026
- [Evia Bio, Inc.](https://specstream.ai/data/form-d/company/evia-bio-inc-1954759) $5.5 million · Sep 28, 2026
- [EyeMacular Regeneration, Inc.](https://specstream.ai/data/form-d/company/eyemacular-regeneration-inc-2042485) $2.9 million · Sep 25, 2026
- [ProEncia Biotechnology Inc.](https://specstream.ai/data/form-d/company/proencia-biotechnology-inc-2103044) $1.5 million · Aug 26, 2026

[Every Form D from the week of Sep 21, 2020](https://specstream.ai/data/form-d/week/2020-09-21) · [All recent filings in Minnesota](https://specstream.ai/data/form-d/state/minnesota) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what OX2 Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).